Koukourakis, Georgios V <br/><br/>
Bevacizumab for Malignant Brain Gliomas. Which is the Current Evidence?  [electronic resource] 

 -  Recent patents on inflammation & allergy drug discovery  2015 
 - 136-43 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1872-213X 
<br/><br/><label>Standard No.: </label>10.2174/1872213x09666150807110031  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--therapeutic use<br/>Bevacizumab--therapeutic use<br/>Brain Neoplasms--drug therapy<br/>Clinical Trials as Topic<br/>Drug and Narcotic Control<br/>Evidence-Based Medicine<br/>Glioma--drug therapy<br/>Humans<br/>Molecular Targeted Therapy<br/>Patents as Topic<br/>Receptors, Vascular Endothelial Growth Factor--antagonists & inhibitors<br/>Signal Transduction--drug effects<br/>Treatment Outcome<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors